News

​Gene causing sickle cell disease removed by scientistsStudy opens door to similar gene-cutting strategies to cure a range of genetic diseasesThu, Jun 24, 2021, 06:00Seán DukeDr Ciaran Lee is based at APC Microbiome Ireland SFI Research Centre in University College Cork. Photograph: Tomas TynerScientists have used a DNA cutting technique to remo...

​French biopharma company Ipsen invests €25m Dublin plantInvestment aimed at boosting capacity of plant to produce ‘transformative medicine’Staff at Ipsen’s Dublin site work in research and development, manufacturing and also on the commercial side of the business.French biopharma company Ipsen is investing €25 million to boost manufacturing cap...

Using platelets as little health sensors in our bloodResearch Lives: Patricia Maguire, Professor of Biomedical Science at University College DublinProft Patricia Maguire receiving the NovaUCD Invention of the year award 2021 on behalf of the team for AI_PREMie. Photograph: Nick BradshawYour research is on blood platelets, what do you find intere...

​Irish scientists make discovery on dangerous Covid clottingWork could help in developing treatments to prevent life-threatening complicationIrish scientists have identified how some Covid-19 patients can develop life-threatening clots, which could lead to targeted therapies to prevent it from happening.The balance between a molecule that causes...

​Irish pharma company APC invests €25m in vaccine manufacture Investment will see the creation of 120 jobs at ‘medicines accelerator’ Thu, Jun 10, 2021, 10:00 Updated: Thu, Jun 10, 2021, 10:19 Dominic Coyle Process development engineer Becca Dunne at APC, the pharmaceutical research a...

Employees want flexibility in where and when they work, EY survey findsUpdated / Monday, 14 Jun 2021 15:06The data shows that nine in ten employees now want flexibility in where and when they workOver half of employees would consider leaving their job post pandemic if they are not given some form of flexibility in where and when they work, accor...

US approves Biogen Alzheimer's drugBiogen said it has priced the drug, to be sold as Aduhelm, at $56,000 per yearUS regulators have approved Biogen's aducanumab as the first treatment to attack a likely cause of Alzheimer's disease, sending its shares soaring, despite controversy over whether the clinical evidence proves the drug works.Biogen sa...

Shannon med-tech firm heads up €5.4m orthopaedic projectThe project, called OsStic, is aiming to develop a bioinspired adhesive that will stick broken bone tissue together.Staff at Shannon-based medical technology firm PBC BioMed which designs, develops, and manufactures medical devices.TUE, 01 JUN, 2021 - 22:07ALAN HEALYShannon-based medical te...

Thousands who lost jobs to get free training in digital skills under recovery planRetrofitting homes to be focus of re-training and new bid to tackle student digital divideMinister for Further and Higher Simon Harris said Covid-19 has accelerated us towards a “digitally dominated economy”. Photograph: Brian Lawless/PA WireSeparately, Minister fo...